(Total Views: 697)
Posted On: 11/05/2020 11:39:45 PM
Post# of 154977
I agree with you and others that it's not likely that the FDA is reviewing our data. But given the increase in cases, it is possible.
It is possible they asked the DSMC to provide the data so they could have an inkling if Leronlimab may work, so that they can begin preparing. Including OWS.
I'm not saying this is happening, just that it is possible
It is also possible that NP made another confusing statement.
It is possible they asked the DSMC to provide the data so they could have an inkling if Leronlimab may work, so that they can begin preparing. Including OWS.
I'm not saying this is happening, just that it is possible
It is also possible that NP made another confusing statement.
(2)
(0)
